These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY; Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686 [TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095 [TBL] [Abstract][Full Text] [Related]
8. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study. Chauchard M; Benali K; Papo T; Sacre K Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889 [TBL] [Abstract][Full Text] [Related]
16. [(18)F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome]. García Vicente AM; Vega Caicedo CH; Mondéjar Solís R; de Ayala Fernández JÁ; Garrido Robles JA; Pena Pardo FJ; Muñoz Pasadas M; Del Saz Saucedo P; Jiménez Londoño GA; León Martín A; Soriano Castrejón Á Rev Esp Med Nucl Imagen Mol; 2015; 34(4):236-43. PubMed ID: 25864422 [TBL] [Abstract][Full Text] [Related]
17. [Positron emission tomography/computed tomography for lung cancer staging]. Ladrón de Guevara H D; Furnaro L F; Yévenes A S; Clavero R JM; Lazo P D; Rodríguez D P; Piottante B A; Pefaur D R; Pardo B C Rev Med Chil; 2015 Jan; 143(1):22-9. PubMed ID: 25860265 [TBL] [Abstract][Full Text] [Related]
18. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [TBL] [Abstract][Full Text] [Related]